5Shah PK, Forresler JS. Pathophysiology of aeule comnary syndromes. Am J Cardinal, 1991, 68: 16C-23C.
6Windecker S, Hern a ndez-Antolln RA, Stefanini GG, et al. Management of ST-elevation myocardial infarclim acctrding to European and American guidelines. Eurolntrvntion, 2014, Suppl T: T23-31.
7Hulmr K, l,ip GY. Diflerenees belween ACC/AHA and ESC Guidelines on antiplalele therapy in palienls with atule cronary syndromes. Thromb Haemosl, 2013,10: 11-13.
8Serebruany V, DiNicolantonio J. Mismatch between the european and american guidelines on oral antiplatelet P2Y 12 inhibitors after acute coronary syndromes. Thrmlb Haemost, 2013, 110: 5-10.
9Mehta SR, Tanguay JF, Eikelboom JW, et al. Double-dose versus standard-dose clopidogrel and high-dse versus low-dse aspirin in individuals undergoing percalaneos coronary intervenlion for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial. Lancet, 2010, 376:1233-1243.
10Wallentin L, Becker R, Budaj A, el al. for the PLATO Investigators. Ticagrelor versus clopidogrel in patients with acute cnrmary syndromes. N Engl J Med, 2009, 361: 1045-1057.